Johnson Financial Group LLC (Colorado)’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$880K Sell
6,967
-55
-0.8% -$7.25K 0.05% 102
2026
Q1
$979K Buy
7,022
+4,711
+204% +$660K 0.07% 56
2025
Q4
$284K Sell
2,311
-637
-22% -$77.4K 0.02% 96
2025
Q3
$327K Buy
2,948
+798
+37% +$90.7K 0.03% 60
2025
Q2
$238K Sell
2,150
-1,083
-33% -$115K 0.02% 68
2025
Q1
$362K Buy
+3,233
New +$334K 0.04% 57

Other funds holding GILD

Johnson Financial Group LLC (Colorado)'s GILD Position: Q2 2026 in Review

Johnson Financial Group LLC (Colorado) reduced its Gilead Sciences (GILD) stake by 0.78% in Q2 2026, selling an estimated $7.25K and leaving 6,967 shares worth $880K. The position accounts for 0.05% of the portfolio, ranked #102.

Johnson Financial Group LLC (Colorado) first reported a position in GILD in Q1 2025 and has held it in 6 quarters since. The position peaked at $979K in Q1 2026. 2,292 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Johnson Financial Group LLC (Colorado) held 6,967 shares of Gilead Sciences worth $880K as of Q2 2026.
  • Johnson Financial Group LLC (Colorado) sold 55 Gilead Sciences shares in Q2 2026, an estimated $7.25K.
  • Gilead Sciences made up 0.05% of Johnson Financial Group LLC (Colorado)'s portfolio in Q2 2026, its #102 holding.
  • Johnson Financial Group LLC (Colorado) first reported a position in Gilead Sciences in Q1 2025 and has held it in 6 quarters since.
  • Johnson Financial Group LLC (Colorado)'s Gilead Sciences position peaked at $979K in Q1 2026.
  • 2,292 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Johnson Financial Group LLC (Colorado)'s 13F filing for Q2 2026, filed 6 Aug 2026.